|
Home
CME Live Seminars
About the Program
Quick Order
Hotel Registration
Auto Rental
Accreditation
Cancellation Policy
Testimonials
CME Video DVD
CME Audio CD/MP3
Subscribe
Request Brochure
Hold Seat
Testing Online
Faculty
Resources
Contact Us
|
|
|
|
Live CME Seminars
Pediatric Infectious Diseases CME |
|
|
by Stephen C. Eppes, M.D., F.A.A.P. - Jefferson Medical College, Thomas Jefferson University; Professor of Pediatrics; Associate Director of Infectious Diseases, Alfred I. duPont Hospital for Children, Wilmington, DE and Michael J. Muszynski, M.D., F.A.A.P. - Florida State University College of Medicine; Regional Campus Dean and Professor of Clinical Sciences; Staff Physician, Arnold Palmer Hospital for Children, Orlando, FL.
Learning Objectives
What do our past participants have to say?
Refer a Colleague to Our Website
|
|
NARRATIVE DESCRIPTION: Following this course, the participant should be able to recognize the epidemiology and classify commonly presenting infectious diseases; identify the various serious infections requiring immediate therapy; choose appropriate lab evaluation and identify when to refer to a specialist. This activity is expected to result in increased confidence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.
The emphasis will be on current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives, with a focus on diagnosis, treatment and when to refer. Since Infectious Diseases is a specialty field of medicine that affects all areas of Primary Care to include: FM, IM, EM and Pediatrics, this course was designed to cover the spectrum of Infectious Diseases essential to all practitioners at the level of a practicing physician.
| | Day 1 |
Pediatric Immunization Update. Antibiotic Update. Serious Infections of the Head and Neck. The Child with “Too Many” Infections. |
| Day 2 |
The Age of MRSA. Cases from the Files of a Pediatric ID Consultant. Chief Complaint: Fever and Rash. Kawasaki Disease. |
| Day 3 |
Acute Otitis Media: Of Pathogens and Patients. Tick-Borne Infections: Hot Spots and Bullseyes. Fever in Infants. Pediatric Lower Respiratory Infections. |
| Day 4 |
Virus X: Ubiquitous, Uncanny, Understandable. Influenza: What’s New and What You Can Do. Urinary Tract Infections. Infectious Diseases Walking Through Your Office Door. |
| Day 5 |
Pediatric Meningitis Revisited. Cat Scratch Disease: Old and New. Lymphadenopathy in Children: Diagnostic Approach. Clinical Approach to Congenital Infections. |
|
|
Pediatric Infectious Diseases: An Evidence-Based Approach
April 26-30, 2010
Location: Hyatt Regency Sarasota, Florida
| SPECIFIC OBJECTIVES
| | Day 1 | Pediatric Immunization Update - Upon completion of this session, using information published by the CDC and AAP, the participant should be able to:
| 1. | Describe the relevant epidemiology of specific vaccine-preventable diseases.
| | 2. | Appropriately use newer vaccines.
| | 3. | Approach the problem of vaccine refusal.
| | Antibiotic Update - Upon completion of this session, the participant should be able to:
| | 1. | Review recent trends in antibiotic resistance.
| | 2. | Improve empiric antibiotic usage for common pediatric conditions.
| | 3. | Develop strategies to resist further bacterial resistance, as recommended by the CDC.
| | Serious Infections of the Head and Neck - Upon completion of this session, the participant should be able to:
| | 1. | Recognize differences and similarities in the clinical appearance, diagnosis and treatment of peritonsillar, retropharyngeal and parapharyngeal space infections.
| | 2. | Outline the approach to the child with red, swollen eye or cheek.
| | The Child with “Too Many” Infections - Upon completion of this session, the participant should be able to:
| | 1. | Perform an office-based evaluation of the child with frequent infections.
| | 2. | Recognize the presentation of the most common causes of recurrent infections in childhood, decide when to consider immune deficiency states, then define the management issues for physician providing pediatric healthcare.
|
| | Day 2 | The Age of MRSA - Upon completion of this session and using the evidence-based guidelines from the CDC, the Pediatric Infectious Diseases Society, and EBM publications, the participant should be able to:
| 1. | Describe the emergence and development of drug resistance that led to MRSA.
| | 2. | Discuss the prevalence differences and clinical diagnosis and treatment of community and hospital associated MRSA.
| | 3. | Recognize the importance of accurate and timely diagnosis when confronted with the possibility of MRSA.
| | 4. | Stratify management according to clinical scenario and severity.
| | 5. | Apply practical and proven preventative measures to reduce the risk and incidence of MRSA.
| | Cases from the Files of a Pediatric ID Consultant - Upon completion of this session, the participant should be able to:
| | 1. | Learn from instructive pediatric infectious diseases cases and be able to construct approaches to a variety of interesting clinical challenges as presented to the ID consultant.
| | 2. | Recognize that non-infectious conditions may masquerade as infectious diseases and that the history is the key to most diagnoses.
| | Chief Complaint: Fever and Rash - Upon completion of this session, the participant should be able to:
| | 1. | Recognize distinctive clinical illnesses with fever and rash.
| | 2. | Develop an approach to clinical and laboratory diagnosis.
| | Kawasaki Disease - Upon completion of this session, the participant should be able to:
| | 1. | Recognize clinical/laboratory manifestations of Kawasaki disease.
| | 2. | Evaluate and manage patients according to AAP/AHA guidelines.
| | 3. | Recognize the potential for coronary complications.
|
| | Day 3 | Acute Otitis Media: Of Pathogens and Patients - Upon completion of this session, the participant should be able to:
| 1. | Recognize trends in resistance in pediatric pathogens.
| | 2. | Identify key recommendations in AAP/AAFP guidelines.
| | 3. | Appropriately prescribe empiric antibiotic therapy.
| | Tick-Borne Infections: Hot Spots and Bullseyes - Upon completion of this session, the participant should be able to:
| | 1. | Appreciate the epidemiology of tick-borne infections.
| | 2. | Recognize the clinical/laboratory manifestations.
| | 3. | Appropriately prescribe therapy, incorporating recent IDSA guidelines.
| | Fever in Infants - Upon completion of this session, and using the evidence-based guidelines from EBM publications, the participant should be able to:
| | 1. | Identify the common bacterial pathogens associated with fever in infants < 8 weeks of age as compared to older infants.
| | 2. | Discuss the rationale for current diagnostic evaluation in these patients.
| | 3. | Apply the appropriate treatment options for this patient population.
| | Pediatric Lower Respiratory Infections - Upon completion of this session, and using the evidence-based guidelines from EBM publications, the participant should be able to:
| | 1. | Recognize the association of age, seasonal, clinical presentation, and chest x-ray findings with etiology of pediatric pneumonia.
| | 2. | Describe the diagnostic approach to infants and children suspected to have pneumonia and discuss the treatment options and the implications of emerging bacterial resistance.
|
| | Day 4 | Virus X: Ubiquitous, Uncanny, Understandable - Upon completion of this session, the participant should be able to:
| 1. | Discuss the pathophysiology of Epstein-Barr virus infection.
| | 2. | Recognize the diverse clinical manifestations of EBV infection.
| | 3. | Order appropriately laboratory work-up based on the situation.
| | Influenza: What’s New and What You Can Do - Upon completion of this session, the participant should be able to:
| | 1. | Identify recent changes in influenza epidemiology.
| | 2. | Enumerate recommendations for immunization.
| | 3. | Describe options for antiviral prophylaxis and treatment.
| | Urinary Tract Infections - Upon completion of this session and using the evidence-based guidelines from the AAP, the participant should be able to:
| | 1. | Describe the clinical situations in which urinary tract infections should be considered.
| | 2. | Identify diagnostic methods for urinary tract infection, characterize their reliability and application, and list their limitations.
| | 3. | Select the most appropriate treatment options.
| | 4. | Discuss the controversies concerning follow-up and prevention strategies.
| | Infectious Diseases Walking Through Your Office Door - Upon completion of this session using the evidence-based guidelines from the AAP and the Red Book, the participant should be able to:
| | 1. | Prepare for common and emerging infectious diseases.
| | 2. | Recognize important symptoms and signs.
| | 3. | Formulate a plan for management.
|
| | Day 5 | Pediatric Meningitis Revisited - Upon completion of this session, the participant should be able to:
| 1. | Discuss common presenting features of bacterial and viral meningitis.
| | 2. | Identify the pathogens and treatment concerning bacterial meningitis in children.
| | 3. | Recognize the management priorities and potential complications of bacterial meningitis.
| | 4. | Explain the effects of immunizations practices on bacterial meningitis.
| | Cat Scratch Disease: Old and New - Upon completion of this session, the participant should be able to:
| | 1. | Recognize the classic and more recently described clinical presentation of cat scratch disease and the general approach to diagnosis.
| | 2. | Explain the use and limitations of diagnostic laboratory testing options.
| | 3. | Utilize the appropriate treatment for the various clinical conditions associated with Bartonella henselae infection.
| | Lymphadenopathy in Children: Diagnostic Approach - Upon completion of this session, the participant should be able to:
| | 1. | Differentiate serious from reactive adenopathy.
| | 2. | Approach patient based on location and tempo of adenopathy.
| | 3. | Use appropriate laboratory aids in diagnosis.
| | Clinical Approach to Congenital Infections - Upon completion of this session, the participant should be able to:
| | 1. | Recognize clinical / laboratory evidence of different infections.
| | 2. | Discuss the role maternal serologic testing.
| | 2. | Provide therapy and long-term management plans.
|
|
|